Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Prevalence of IgG antibodies to SARS-CoV-2 in Wuhan – implications for the ability to produce long-lasting protective antibodies against SARS-CoV-2

Tao Liu, Sanyun Wu, Huangheng Tao, Guang Zeng, Fuling Zhou, View ORCID ProfileFangjian Guo, View ORCID ProfileXinghuan Wang
doi: https://doi.org/10.1101/2020.06.13.20130252
Tao Liu
1Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sanyun Wu
2Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Huangheng Tao
3State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) and Key Laboratory for Oral Biomedicine of Ministry of Education (KLOBM), School and Hospital of Stomatology, Wuhan University, Wuhan, Hubei
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guang Zeng
1Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fuling Zhou
2Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fangjian Guo
4Department of Obstetrics & Gynecology, The University of Texas Medical Branch at Galveston, Galveston, TX
5Center for Interdisciplinary Research in Women’s Health, The University of Texas Medical Branch at Galveston, Galveston, TX
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Fangjian Guo
Xinghuan Wang
1Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Xinghuan Wang
  • For correspondence: wangxinghuan@whu.edu.cn faguo@utmb.edu zhoufuling@whu.edu.cn
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Article Information

doi 
https://doi.org/10.1101/2020.06.13.20130252
History 
  • June 16, 2020.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Tao Liu, MD1,*,
  2. Sanyun Wu, MD, PhD2,*,
  3. Huangheng Tao, PhD3,*,
  4. Guang Zeng, MD1,
  5. Fuling Zhou, MD2,†,
  6. Fangjian Guo, MD, PhD4,5,† and
  7. Xinghuan Wang, MD1,†,‡
  1. 1Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei
  2. 2Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei
  3. 3State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) and Key Laboratory for Oral Biomedicine of Ministry of Education (KLOBM), School and Hospital of Stomatology, Wuhan University, Wuhan, Hubei
  4. 4Department of Obstetrics & Gynecology, The University of Texas Medical Branch at Galveston, Galveston, TX
  5. 5Center for Interdisciplinary Research in Women’s Health, The University of Texas Medical Branch at Galveston, Galveston, TX
  1. ↵‡Correspondence to: Xinghuan Wang, MD
    , Department of Urology, Zhongnan Hospital of Wuhan University, No. 169 Donghu Road, Wuchang District, Wuhan, Hubei 430071, China, Email: wangxinghuan{at}whu.edu.cn and Fangjian Guo, MD, PhD
    , Department of Obstetrics & Gynecology, Center for Interdisciplinary Research in Women’s Health, The University of Texas Medical Branch at Galveston, 301 University Blvd, Galveston, TX 77555-0587, Tel: (409) 772-8599, Email: faguo{at}utmb.edu and Fuling Zhou, MD
    , Department of Hematology, Zhongnan Hospital of Wuhan University, No. 169 Donghu Road, Wuchang District, Wuhan, Hubei 430071, China, Email: zhoufuling{at}whu.edu.cn
  1. ↵* Contributing equally

  2. ↵† Contributing equally

  3. Author Contributions: Dr. X. Wang had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Drs T. Liu, S. Wu and H. Tao contributed equally to the study. Drs F. Zhou, F. Guo, and X. Wang contributed equally as senior authors. Concept and design: F. Zhou and X. Wang. Acquisition, analysis, or interpretation of data: T. Liu, S. Wu and H. Tao, Guang Zeng. Drafting of the manuscript: T Liu, S. Wu, F. Guo. Critical revision of the manuscript for important intellectual content: S. Wu, X. Wang. Statistical analysis: T. Liu, H. Tao.

Back to top
PreviousNext
Posted June 16, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Prevalence of IgG antibodies to SARS-CoV-2 in Wuhan – implications for the ability to produce long-lasting protective antibodies against SARS-CoV-2
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Prevalence of IgG antibodies to SARS-CoV-2 in Wuhan – implications for the ability to produce long-lasting protective antibodies against SARS-CoV-2
Tao Liu, Sanyun Wu, Huangheng Tao, Guang Zeng, Fuling Zhou, Fangjian Guo, Xinghuan Wang
medRxiv 2020.06.13.20130252; doi: https://doi.org/10.1101/2020.06.13.20130252
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Prevalence of IgG antibodies to SARS-CoV-2 in Wuhan – implications for the ability to produce long-lasting protective antibodies against SARS-CoV-2
Tao Liu, Sanyun Wu, Huangheng Tao, Guang Zeng, Fuling Zhou, Fangjian Guo, Xinghuan Wang
medRxiv 2020.06.13.20130252; doi: https://doi.org/10.1101/2020.06.13.20130252

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (227)
  • Allergy and Immunology (500)
  • Anesthesia (110)
  • Cardiovascular Medicine (1227)
  • Dentistry and Oral Medicine (205)
  • Dermatology (147)
  • Emergency Medicine (282)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (528)
  • Epidemiology (10001)
  • Forensic Medicine (5)
  • Gastroenterology (497)
  • Genetic and Genomic Medicine (2443)
  • Geriatric Medicine (236)
  • Health Economics (479)
  • Health Informatics (1635)
  • Health Policy (751)
  • Health Systems and Quality Improvement (633)
  • Hematology (247)
  • HIV/AIDS (530)
  • Infectious Diseases (except HIV/AIDS) (11855)
  • Intensive Care and Critical Care Medicine (625)
  • Medical Education (251)
  • Medical Ethics (74)
  • Nephrology (267)
  • Neurology (2272)
  • Nursing (139)
  • Nutrition (349)
  • Obstetrics and Gynecology (451)
  • Occupational and Environmental Health (532)
  • Oncology (1244)
  • Ophthalmology (375)
  • Orthopedics (133)
  • Otolaryngology (226)
  • Pain Medicine (154)
  • Palliative Medicine (50)
  • Pathology (324)
  • Pediatrics (729)
  • Pharmacology and Therapeutics (311)
  • Primary Care Research (281)
  • Psychiatry and Clinical Psychology (2280)
  • Public and Global Health (4823)
  • Radiology and Imaging (833)
  • Rehabilitation Medicine and Physical Therapy (488)
  • Respiratory Medicine (650)
  • Rheumatology (283)
  • Sexual and Reproductive Health (237)
  • Sports Medicine (224)
  • Surgery (266)
  • Toxicology (44)
  • Transplantation (124)
  • Urology (99)